www.fdanews.com/articles/134368-genzyme-after-months-of-holding-out-agrees-to-be-sold-to-sanofi-aventis-for-20-1b
Genzyme, After Months of Holding Out, Agrees to Be Sold to Sanofi-Aventis for $20.1B
February 16, 2011
It’s been a long time coming, but the sale of Genzyme, the Cambridge, MA-based biotech company, to pharma giant Sanofi-Aventis for $20.1 billion marks a landmark moment in the biotech industry here in Boston and beyond.
Xconomy
Xconomy